MED - Latest News

Medifast, Inc. (MED), operates in Consumer Cyclical / Personal Products & Services, trades on NYSE.

Market capitalization stands near $138.8M. Beta to the broader market is 0.57.

The article list below shows the most recent MED headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent MED Headlines

Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation

globenewswire.com - May 15, 2026

Body composition, specifically visceral fat levels and lean mass, plays a meaningful role in long-term metabolic health (Serra MC, et al. , 2019) Stru

Peer-Reviewed Research Is Redefining Weight Loss Program Standards

globenewswire.com - May 15, 2026

The global weight loss industry was valued at $16. 3 billion in 2025, yet peer-reviewed clinical validation of program outcomes remains uneven across

Why Medifast's $15 Cash Per Share Makes It A Strong Buy

seekingalpha.com - May 13, 2026

Medifast trades below net cash value, with $15 per share in cash versus a $12. 60 share price, creating a compelling value floor.

Medifast: Worth Putting On A Watchlist

seekingalpha.com - May 12, 2026

Medifast has continued to report concerning financials. A shrinking coach network lowers revenues, and costs remain too high.

Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y

zacks.com - May 5, 2026

MED beats first-quarter estimates despite steep revenue declines, while stronger coach productivity and a new product launch support recovery hopes.

How News Affects MED Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MED's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked MED news questions

What is the latest MED news headline?

The most recent MED headline (May 15, 2026) is "Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the MED news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What MED news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual MED options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.